LivaNova PLCLIVN
What LivaNova PLC does.
LivaNova PLC is a market-leading global medical technology company. The Company designs, develops, manufactures, markets, and sells products, therapies, and services that are consistent with LivaNova’s mission to “create ingenious medical solutions that ignite patient turnarounds.” LivaNova is a public limited company organized under the laws of England and Wales and is headquartered in London, England. LivaNova’s ordinary shares are listed for trading on the Nasdaq under the symbol “LIVN.”
LivaNova identifies operating segments based on how it manages, evaluates, and internally reports its business activities to allocate resources, develop and execute its strategy, and assess performance. LivaNova has two reportable segments: Cardiopulmonary and Neuromodulation. “Other” includes non-allocated corporate expenses and the non-cannula results of the Company’s former ACS segment, which was wound down during 2024.
For additional information regarding LivaNova’s reportable segments, historical financial information, and methodology for the presentation of financial results, refer to “Part IV, Item 15. Exhibits and Financial Statement Schedules” of this Report.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $934.2M | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| Net income | -$348.8M | -$135.8M | -$86.2M | $17.5M | $63.2M | -$242.5M |
| Free cash flow | -$114.4M | $77.1M | $43.4M | $39.9M | $135.9M | $173.3M |
More on LIVN.
- LivaNova PLC summary
- LivaNova PLC financial statements
- LivaNova PLC key metrics
- LivaNova PLC health scores and style box
- LivaNova PLC earnings
- LivaNova PLC dividends
- LivaNova PLC valuation
- LivaNova PLC ownership and insiders
- LivaNova PLC peers
Figures from LivaNova PLC's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.